Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
As stakeholders grapple with shortages and the emergence of compounded alternatives, its crucial to understand the current landscape and its implications for pharmacy benefits management
Increase of 2,3-epoxybutane mutagenicity by glutathione-S-transferases [PMID: 6377584] Laboratory literature summary: Increase of 2,3-epoxybutane mutagenicity by glutathione-S-transferases
Signs of dehydration : decreased urination, dark urine, dizziness, or extreme thirst
Safety Precautions and Considerations Combination therapy increases the importance of safety screening
These reactions reduce the amount of active drug available for therapeutic effect
US$ 20.66
US$ 21.12
US$ 24.50
US$ 22.42
US$ 27.51
US$ 22.12
